MANN MICHAEL SCOTT (President) purchased 0.1% of their position (14K shares) of ENDONOVO THERAPEUTICS, INC. on the open market
Open‑market purchase worth $482.50 — a small addition. The strongest form of insider conviction signal.
Common Stock
Shares
+1K
Price / share
$0.04
Trade value
$37.50
% of position
Common Stock
Shares
+2K
Price / share
$0.04
Trade value
$73.60
% of position
Common Stock
Shares
+1K
Price / share
$0.04
Trade value
$36.60
% of position
Common Stock
Shares
+1K
Price / share
$0.03
Trade value
$34.60
% of position
Common Stock
Shares
+2K
Price / share
$0.03
Trade value
$69.40
% of position
Common Stock
Shares
+2K
Price / share
$0.03
Trade value
$69.20
% of position
Common Stock
Shares
+2K
Price / share
$0.03
Trade value
$68.60
% of position
Common Stock
Shares
+2K
Price / share
$0.03
Trade value
$63.00
% of position
Common Stock
Shares
+1K
Price / share
$0.03
Trade value
$30.00
% of position
Net shares
+14K
Net value
$482.50
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/14/2018 | P · Purchase | +1K | $0.04 | $37.50 | 0.0% | 26.15M | 26.15M |
| Common Stock Direct | 11/14/2018 | P · Purchase | +2K | $0.04 | $73.60 | 0.0% | 26.15M | 26.15M |
| Common Stock Direct | 11/15/2018 | P · Purchase | +1K | $0.04 | $36.60 | 0.0% | 26.15M | 26.15M |
| Common Stock Direct | 11/15/2018 | P · Purchase | +1K | $0.03 | $34.60 | 0.0% | 26.15M | 26.15M |
| Common Stock Direct | 11/15/2018 | P · Purchase | +2K | $0.03 | $69.40 | 0.0% | 26.15M | 26.15M |
| Common Stock Direct | 11/15/2018 | P · Purchase | +2K | $0.03 | $69.20 | 0.0% | 26.15M | 26.16M |
| Common Stock Direct | 11/16/2018 | P · Purchase | +2K | $0.03 | $68.60 | 0.0% | 26.16M | 26.16M |
| Common Stock Direct | 11/19/2018 | P · Purchase | +2K | $0.03 | $63.00 | 0.0% | 26.16M | 26.16M |
| Common Stock Direct | 11/19/2018 | P · Purchase | +1K | $0.03 | $30.00 | 0.0% | 26.16M | 26.16M |
| Total | +14K | $482.50 | ||||||